Can ZEB2 Be Used as a Molecular Marker for Risk Stratification of Patients With Colorectal Cancer?
JAMA Netw Open
.
2018 Oct 5;1(6):e183133.
doi: 10.1001/jamanetworkopen.2018.3133.
Authors
Joceline V Vu
1
,
Ana De Roo
1
,
Karin M Hardiman
2
Affiliations
1
Department of Surgery, Michigan Medicine, Ann Arbor.
2
Division of Colorectal Surgery, Department of Surgery, Michigan Medicine, Ann Arbor.
PMID:
30646215
DOI:
10.1001/jamanetworkopen.2018.3133
No abstract available
Publication types
Comment
MeSH terms
Biomarkers
Colorectal Neoplasms*
Humans
Risk Assessment
Zinc Finger E-box Binding Homeobox 2
Substances
Biomarkers
ZEB2 protein, human
Zinc Finger E-box Binding Homeobox 2